U.S. Senator Tammy Baldwin Demands Answers About Outrageous Price Hike For Lifesaving Anti-Overdose Drug
"...this startling price hike is very concerning."
WASHINGTON, D.C. – U.S. Senator Tammy Baldwin joined a group of thirty-one Senators, led by Senator Patrick Leahy (D-VT), in demanding answers from a leading pharmaceutical company about the dramatic price hike for a life-saving medication used to respond to opioid overdoses.
Recent reports unveiled that drug maker Kaléo Pharmaceuticals, which manufactures an easy-to-use injector device containing the overdose-reversing drug naloxone, raised its price from $690 in 2014, to $4,500 currently. While the Evzio device has the potential to help thousands of individuals survive drug overdoses, the Senators wrote that the inexplicable price hike “threatens to price-out families and communities that depend on naloxone to save lives.”
The bipartisan Comprehensive Addiction and Recovery Act (CARA), which was signed into law last year, includes a Leahy-authored provision to help rural communities obtain the overdose-reversing drug naloxone. Rural locations have the highest death rates in the country from opioid poisoning, and Naloxone has the potential to save more lives in these areas.
In addition to Baldwin and Leahy, the letter was signed by Senators Al Franken (D-MN), Christopher Murphy (D-CT), Jack Reed (D-RI), Dick Durbin (D-IL), Sheldon Whitehouse (D-RI), Maria Cantwell (D-WA), Dianne Feinstein (D-CA), Claire McCaskill (D-MO), Jeanne Shaheen (D-NH), Angus King (I-ME), Richard Blumenthal (D-CT), Edward J. Markey (D-MA), Maggie Hassan (D-NH), Amy Klobuchar (D-MN), Heidi Heitkamp (D-ND), Elizabeth Warren (D-MA), Tammy Duckworth (D-IL), Kirsten Gillibrand (D-NY), Joe Donnelly (D-IN), Jon Tester (D-Mont.), Bernie Sanders (I-Vt.), Sherrod Brown (D-Ohio), Debbie Stabenow (D-MI), Tom Udall (D-NM), Tim Kaine (D-VA), Mark Warner, (D-VA), Gary Peters (D-MI), Jeff Merkley (D-OR) and Cory Booker (D-NJ).
A copy of the letter to Kaléo Pharmaceuticals is available here.
Recent Press Releases by U.S. Sen. Tammy Baldwin
Baldwin, Senate Colleagues Urge FDA to Change Discriminatory Blood Donation Policies to Combat Coronavirus PandemicMar 26th, 2020 by U.S. Sen. Tammy Baldwin
As COVID-19 has spurred a nationwide blood shortage, the FDA continues to enforce discriminatory policies prohibiting many healthy gay and bisexual men from donating blood
U.S. Senator Tammy Baldwin Works to Pass Bipartisan Economic Stimulus Legislation to Support Wisconsin Families, Workers, Small Businesses, Hospitals and Our Health Care SystemMar 25th, 2020 by U.S. Sen. Tammy Baldwin
“A strong step forward responding to the public health and economic crisis we face in Wisconsin.”